Seizures are a result of sudden, brief electrical changes or disturbances in the brain. Epilepsy is where there are chronic, recurrent seizures. Some seizures are as a result of metabolic or chemical imbalances, alcohol or drug use, cardiac disease, infectious disease, toxic neurological effects, etc. Syncope involves losing consciousness, but for non-epileptic reasons such reduced blood flow to the brain, hypoglycemia, insulin resistance, etc. Epilepsy affects about 2 million people in the U.S., with a higher incidence of seizures.
The central nervous system has 2 major divisions- central nervous system and peripheral nervous system. The peripheral nervous system has 2 divisions, somatic and autonomic. The autonomic nervous system exercises control over automatic and involuntary functions of the body such as heart rate, respiration, etc. Seizures involve a complex interaction between the autonomic nervous system and the central nervous system. Seizures are often preceded by a partial seizure or aura having varied characteristics, which can warn those susceptible to seizures of an imminent seizure. Some can actually control or prevent actual seizures by preventive or biofeedback measures. Anti-epileptic drugs (AEDs) are commonly used to control seizures but sometimes are not effective and sometimes have adverse long-term health effects, including inducement of birth defects/congenital conditions in use by pregnant women or infants.
Seizure triggers include low blood sugar, dehydration, fatigue, lack of sleep, stress, temperature extremes, depression, flashing lights, allergens, caffeine, alcohol, aspartame, pesticides, and toxic metals. The most common allergen triggers are wheat, milk, and petrochemicals. Identification and avoidance of such triggers usually reduces effects. Caffeine causes release of adrenaline which has blood sugar effects that can trigger seizures. Similar for alcohol, aspartame is an excitotoxin that has trigger effects especially on those subject to depression or mood disorders. MSG is another common exicitotoxin. As will be documented, exposures to mercury from dental amalgams and toxic metals can also commonly trigger and be factors in seizures and epilepsy, with improvement after amalgam replacement and detoxification.
Mercury exposure and chronic health effects
Dental amalgam is the largest source of both inorganic and methylmercury in most who have mercury amalgam fillings. Those with several amalgam fillings have on average at least 10 times as much mercury exposure as those without amalgam fillings. After replacement of mercury amalgam fillings, the level of mercury in saliva and excretion declines approximately 90%. Prior to vaccinations, the largest source of mercury exposure of a fetus or infant is from the mother’s dental amalgam. Over the last decade, most vaccinations contained high levels of mercury and were the largest source of mercury exposure in most infants and young children.
Amalgam dental fillings produce voltaic electrical currents in the teeth, which push high levels of mercury into the gums and oral mucosa and increase mercury vapor release into oral air and saliva, where it is distributed throughout the body and causes significant harmful effects. These currents are measured in micro amps, with some measured at over 4 micro amps. The central nervous system operates on signals in the range of nano-amps, which is 1,000 times less than a micro amp.
These voltaic currents and the resulting high levels of mercury exposure are documented to often have significant neurological effects. Negatively charged fillings or crowns push electrons and mercury into the oral cavity since saliva is a good electrolyte and cause higher mercury vapor losses. Mercury and other metals accumulate in the gums and oral mucosa at the base of teeth with amalgam fillings or metal crowns over amalgam, called mercury tattoos. Patients with autoimmune neurological conditions caused by mercury, like MS, depression, epilepsy, etc., are often found to have a lot of high negative current fillings.
In addition to its extreme neurotoxicity and immunotoxicity, mercury commonly causes autoimmunity, which can also be a factor in conditions like epilepsy, MS, lupus, etc. Prenatal exposure to mercury has been found to predispose animals and infants to seizures and epilepsy.
A major factor in epilepsy has been found to be essential mineral deficiencies and imbalances, such as magnesium, zinc, calcium, etc. Mercury is well-documented to cause cell membrane permeability changes, mineral efflux from cells, leaky gut, and enzyme blockages that commonly result in essential mineral deficiencies and imbalances. Mercury causes significant destruction of stomach and intestine epithelial cells, resulting in damage to stomach and intestinal lining, which along with mercury’s ability to bind to SH hydroxyl radical in cell membranes alters permeability and adversely alters bacterial populations in the intestines causing leaky gut syndrome with toxic incompletely digested complexes in the blood, as well as poor nutrient absorption.
Some of the main mechanisms of toxic effects of metals include: cytotoxicity; changes in cellular membrane permeability; inhibition of enzymes, coenzymes, and hormones; and generation of lipid peroxides or free radicals— which result in neurotoxicity, immuno toxicity, impaired cellular respiration, gastrointestinal /metabolic effects, hormonal effects, and immune reactivity or autoimmunity. Also, mercury binds with cell membranes interfering with sodium and potassium enzyme functions, causing excess membrane permeability, especially in terms of the blood-brain barrier. Less than 1 ppm mercury in the blood stream can impair the blood-brain barrier.
When mercury forms strong bonds with and modifies the-SH groups of proteins, it causes mitochondrial release of calcium, as well as alters molecular function of amino acids and damages enzymatic processes, resulting in improper cysteine regulation, inhibited glucose transfer and uptake, damaged sulfur oxidation processes, reduced glutathione availability (necessary for detoxification), and neurological effects. The essential mineral deficiencies and imbalances have been found to be a major factor in epilepsy, and correcting mineral imbalances has been found to cause significant improvement in epilepsy.
A large epidemiological study by the National Institute of Health, the nation’s principal health statistics agency, found a significant correlation between having a larger number of amalgam fillings and people suffering from conditions such as multiple sclerosis and epilepsy. Fewer of those with these conditions have zero fillings than those of the general population, while more of those with the condition have 17 or more amalgam surfaces than in the general population. Other studies have found similar connections between vaccinations containing mercury and epilepsy. A doctor with extensive experience in researching and treating mercury toxicity has found that blocked nerve ganglions are a common cause of seizures, migraines, and other chronic neurological problems. Based on his experience, Dr. Klinghardt found that the majority of such conditions are due to dental metals and toxins related to root-canaled teeth or improperly healed tooth extraction sites (cavitations). He found that after treatment to unblock the ganglions and mercury detox or cavitation treatment, most patients rapidly recover from such conditions. Numerous other doctors, who he trained through seminars and courses, have had similar experience.
Other doctors treating autism, including seizures which are common in autism, found that mercury and other toxic metals disable the metallothionein function that has several major metabolic and neurological functions. This results in inability to excrete toxic metals, accumulation of mercury and other toxic metals, inability to detoxify mercury and other toxic metals, significant imbalances in zinc/copper levels in the brain and G.I. tract, and major neurological and digestive system effects.
Another researcher who has developed test equipment and tested epilepsy/seizure patients has found the following commonly present in epilepsy/seizure patients: Ascaris (pet hookworm) larvae in brain, bacterial infections, viruses, dental metals, vanadium(natural gas leak), and other toxins including PVC, titanium, zirconium, asbestos, lead, solvents, ergot(mold). The researcher also found that malvin can provoke seizures. After determination of the factors involved for a given patient and treatment, the researcher said most patients are cured. The main treatments are recommended for most cases: dental metal and cavitation checks and cleanups, avoidance and detox of environmental toxins, parasite cleanse, and kidney/liver cleanses. Other doctors have likewise found that patients with toxic exposures and weakened immune systems are more susceptible to parasites and biological invaders which must also be treated.
Alternative Treatments of Epilepsy and Seizures
Most patients with epilepsy recovered or had significant improvement after amalgam replacement and likewise for many with autism and seizures who were treated for mercury toxicity by treatment clinics.
For reasons previously documented and further documented by medical studies and clinical experience in references cited, supplementation alternatives are often beneficial in treatment of seizures and epilepsy. B vitamins, essential minerals, some herbal products, some amino acids and essential fatty acids are often beneficial. Vitamin B6 plays an important role in the conversion of glutamic acid to GABA (gamma-aminobutyric acid). GABA is the principal inhibitory neurotransmitter in the brain. Impairment of GABA neurotransmission processes has been found to often be a factor in seizures. B6 deficiency can result in reduced GABA production. Other B vitamins also are necessary for proper brain function. B13 has been found to reduce seizures in some. Vitamin D and Vitamin E have also been found to be beneficial in reducing seizures and seizure severity. Magnesium deficiency has been shown to increase seizures in some and be a factor in some seizures; manganese aids in sugar metabolism, selenium deficiency can result in deficient glutathione peroxidase which can be a factor in some seizures.
Supplementation of these as well as zinc and calcium have been found to reduce seizures in many. Diet measures including avoidance of obesity and insulin resistance, along with certain amino acids and essential fatty acids have been found to reduce seizures in many. Taurine is an inhibitory amino acid and like GABA has been found to be effective in reducing seizure activity in some. Evening primrose oil has been found to reduce seizures in some. Regular exercise has also been found to reduce seizures in most and to improve general well-being. The herbs Black Cohosh, Lobelia, and coleus forshkohlii extract have been found to be beneficial in some. Relaxation techniques such as yoga and biofeedback techniques have been found helpful by some.
Dr. Ward Dean’s nutritional program for seizure disorders recommends using a nutritional “shotgun” therapy, which includes:
- Atkins Diet
- Magnesium: 500-1,000 mg/day
- Selenium:100-200 mcg/day
- Taurine: 1-3 gm/day
- Carnitine: 1-3 gm/day
- GABA (gamma amino butyric acid) 500-1,000 mg/day
- Vitamin B complex, w/special emphasis on:
- Vitamin B1: 50-100 mg/day
- Vitamin B6: 200-500 mg/day
- Folic Acid: 400-1,000 mcg/day
- Vitamin E: 400-800 IU/day
- Kava Kava: 200-800 mg/day
Huggins says he has a lot of clinical experience that mercury causes epilepsy and replacement often cures it. Others such as Dr. Noel Campbell, Dr. Hulda Clark, and ElectroDermal Screening testers with considerable clinical experience say likewise.
Over 21 years ago, in June 1978, I started taking a large dose of the B Complex vitamins. The dosage was 20mg. B 1, B 2, etc.; B 12 20mcg and folic acid at 400mcg. I immediately felt more energetic and alive. I had grand mal epilepsy for the prior 25 years, since I had entered puberty at age 13. In those days, 20 mg was probably a megadose; I’m not sure. Today I take 50mg because it’s more commonly available. I had been taking anticonvulsant medication trade name Mebroin, including Phenobarbital and a smaller amount of Dilantin. I was able to wean my way off the anticonvulsant medication in July of 1978. I have not taken any medication since and have become a new person.
A study published in the New England Journal of Medicine examined newborns for birth defects related to anticonvulsant drugs. Each newborn belonged to one of three groups: newborns exposed to anticonvulsant drugs in the womb; newborns of mothers with epilepsy who did not take anticonvulsant drugs; and newborns of mothers without epilepsy or a history of seizures. Results showed birth defects were more frequent in infants exposed to anticonvulsant drugs(20% of infants exposed to one drug had birth defects and 28% of infants exposed to two or more drugs had birth defects). However, the infants of mothers with epilepsy who were not treated with anticonvulsant drugs were at no greater risk of birth defects then infants of mothers without epilepsy.
This study suggests birth defects are caused by anticonvulsant drugs and not by epilepsy itself. A separate, earlier study based on data from a number of different countries identified the types of birth defects associated with common anticonvulsant drugs. Some of these findings are summarized below:
Side Effect Warning for New Rheumatoid Arthritis Drug, Remicade (Infliximab)
All drugs have side effects, but some of them don’t become apparent until after the drugs have been approved and in use for some time.
Remicade (infliximab), a powerful new drug for rheumatoid arthritis, has been found to worsen congestive heart failure. The drug was actually being tested to see if it would help patients with congestive heart failure. Instead, the opposite was seen in a trial involving 150 people with moderate to severe congestive heart failure. Of the 101 subjects treated with Remicade, 7 died. In contrast, no fatalities occurred in the 49 patients being treated with the sugar pill placebo.
Some 2 million Americans suffer from rheumatoid arthritis, while 5 million have congestive heart failure. So an undetermined number must have both illnesses. As a result, Centocor, the company making Remicade, after consultation with the U.S. Food and Drug Administration, has sent letters to doctors urging that patients with both rheumatoid arthritis and congestive heart failure not be treated with their drug.
November 2001 Update: This new information comes straight from the National Institute of Health, the NHANES III Study (National Health and Nutritional Examination Survey), a study that according to the mission statement of National Center for Health Sciences is to provide statistical information that will guide the actions and policies to improve health of the American people. As the Nation’s principal health statistics agency, NCHS leads the way with accurate, relevant, and timely data. A recent statistical analysis of this data was done to see if there were any links to dental fillings and adverse health conditions. Their initial figures revealed that while 78% of the American public have dental fillings. 95% of the people with International Classification of Disease Codes 340-349: Disorders of the Central Nervous System, which includes MS, epilepsy, paralysis and migraines, have dental fillings.
Prenatal Mercury Exposure Raises Blood Pressure
Exposure to mercury before birth may lead to increased blood pressure in childhood, reports an international team of researchers. The islanders consume a diet rich in marine products, such as pilot whale meat, which expose them to mercury. Blood pressures increased by about 14 points as blood mercury concentrations at birth increased from 1 to 10 micrograms per liter. The report indicates that 10 micrograms per liter corresponds to the upper limit of mercury exposure recommended by the German Commission on Human Bio-monitoring, indicating that blood pressure can be increased by exposure to mercury levels below recommended limits. Children with lower birth weights experienced blood pressure increases about 50% higher than normal birth weight children having similar mercury levels. The investigators cite evidence that mercury toxicity can cause high blood pressure that persists long after the mercury exposure has been removed, resulting in a significant risk for diseases such as heart attack and stroke.
The prestigious New England Journal of Medicine published an editorial calling mercury fillings the chief source of mercury exposure to the US population.
The effects of chronic, low-dose fetal and lactational organic (MeHgCl) and inorganic (HgCl2) mercury intoxication on epileptogenicity were investigated and compared in rats. The main observations after both mercury treatments were a facilitated seizure expression and propagation evoked by 4-aminopyridin (4-AP). The seizure susceptibility of the offspring seemed to be in a parallel relation to the mercury concentration in the cortical tissue, which was significantly higher in treated animals as compared to the controls. While MeHgCl enhanced the number of ictal periods, HgCl2 facilitated the duration of seizure discharges in younger animals. HgCl2 intoxication seemed to be more permanent than MeHgCl. Changes in the summated ictal activity, which is an indication of epileptogenicity, were observed in the opposite directions in the two treated groups with increasing age. The amplitudes of seizure discharges were smaller in both mercury-treated groups than in the controls, which could be a consequence of a depressed proliferation of neurons or enhanced cell death in the neocortex. In summary, we observed that adult rats exposed to organic or inorganic mercury chemicals during their embryonic life are more prone to epilepsy than control rats given only 4-AP.
Thimerosal Analysis Summary
The results of the Generation Zero analyses are striking and more supportive of a causal relationship between vaccine mercury exposure and childhood developmental disorders (especially autism) than any of the results reported later. Relative risks of autism, ADD, sleep disorders and speech/language delay were consistently relative to other disorders and frequently significant. Disease risk for the high groups ranged from lows of 1.5X-2 times to as high as 11 times the disease risk of the zero exposure group. Many other outcomes showed no consistent effect, while a few appeared to show a protective effect from vaccine mercury exposure (most likely children with these diagnoses immunized later). The strongest effect was for the highest levels of mercury exposure at the earliest time of exposure, consistent with the idea that infant brain development is most sensitive to the earliest exposures.
The elevated risk of autism for the highest exposure levels at one month ranged from 7.6 to 11.4 times the zero exposure level. This increased risk level corresponds to the tenfold increase in autism rates seen since vaccine mercury exposures increase starting in 1990.
Diagnoses with elevated risks
- 399.0 Autism
- 307.0 Stammering
- 307.2 Tics
- 307.20 Tic disorder, unspecified
- 307.4 Specific disorders of sleep of non-organic
- 307.45 Phase shift disruption of 24 hr. sleepwake
- 307.46 Somnambulism or night terrors
- 314.0 Attention deficit disorder
- 314.00 ADD without mention of hyperactivity
- 314.01 ADD with hyperactivity
- 315.3 Developmental speech or language disorder
- 315.31 Developmental language disorder
- 315.39 Other developmental speech or language
- 315.4 Coordination disorder
- 583 Nephritis and nephropathy, not acute or chronic
- 583.9 Nephritis and nephropathy, with unspecified pathological lesion in kidney
1. Huggins HA, Levy,TE. Uniformed Consent: The Hidden Dangers in Dental Care. Hampton Roads Publishing Company Inc. 1999.
2. Huggins HA. It’s All in Your Head. Hampton Roads Publishing Company Inc., 1997.
3. Toxic Elements Research Foundation, Colorado Springs Colorado. Survey of 1320 patients being treated for heavy metal toxicity. 2001.
4. Klinghardt D. Migraines, seizures, and mercury toxicity. Future Medicine Publishing. 1997; 21.
5. Szasz A, Barna B, et al. Effects of continuous low-dose exposure to organic and inorganic mercury during development on epileptogenicity in rats. Neurotoxicology. 2002 Jul; 23(2):197-206.
6. Stejskal J, Stejskal V. The role of metals in autoimmune diseases and the link to neuroendocrinology. Neuroendocrinology Letters. 1999; 20: 345-358.
7. Davis, M. Defense Against Mystery Syndromes. Printing Co., March, 1994.
8. Great Plains Laboratory Website. www.greatplainslaboratory.com/test19.html
9. Psychiatric Disturbances and Toxic Metals. Townsend Letter for Doctors & Patient. April 2002.
10. Vitamin Research Products. www.vrp.com/
11. Shrestha KP, Oswaldo A. Trace elements in hair of epileptic and normal subjects. Total Environ. 1987 Dec; 67(2-3): 215-25.
12. Boadi WY, et al. In vitro effect of mercury on enzyme activities and its accumulation in the first-trimester human placenta. Environ Res. 1992, 57(1): 96-106.
13. Boadi WY, et. al. In vitro exposure to mercury and cadmium alters term human placental membrane fluidity. Pharmacol. 1992, 116(1): 17-23.
14. Urbach J, et al. Effect of inorganic mercury on in vitro placental nutrient transfer and oxygen consumption. Reprod Toxicol. 1992; 6(1): 69-75.
15. Karp W, Gale TF, et al. Effect of mercuric acetate on selected enzymes of maternal and fetal hamsters. Environmental Research. 1985; 36: 351-358.
16. W.B. Karp et al, Correlation of human placental enzymatic activity with trace metal concentration in placenta. Environmental Research. 1977; 13:470- 477.
17. Boot JH. Effects of SH-blocking compounds on the energy metabolism and glucose uptake in isolated rat hepatocytes. Cell Struct Funct. 1995 Jun; 20(3): 233-8.
18. Semczuk M, Semczuk-Sikora A. New data on toxic metal intoxication (Cd, and Hg in particular) and Mg status during pregnancy. Med Sci Monit. 2001 Mar; 7(2): 332-340.
19. Iioka H, et al. The effect of inorganic mercury on placental amino acid transport. Nippon sanka Fujinka Gakkai Zasshi. 1987; 39(2): 202-6.
20. Goyer, RA. Toxic effects of metals In: Toxicology: The Basic Science of Poisons. Ed. Caserett, Doull. New York: McGraw-Hill Inc. 1993.
21. Goodman, Gillman. The Pharmacological Basis of Therapeutics. New York: Mac Millan Publishing Company. 1985.
22. International Labour Organization. Encyclopedia of occupational health and safety. www.ilo.org/safework/WCMS_113329/lang–en/index.htm
23. Drew A. Poisoning: Toxicology, Symptoms, Treatment. 5th ed. Springfield, IL: Charles C. Thomas-Publisher. 1986.
24. Goyer RA, National Institute of Environmental Health Sciences. Toxic and essential metal interactions. Annu Rev Nutr. 1997; 17: 37-50.
25. Lindh U, Carlmark B, Gronquist SO, Lindvall A. Metal exposure from amalgam alters the distribution of trace elements in blood cells and plasma. Clin Chem Lab Med. 2001 Feb; 39(2): 134-142.
26. Goldberg AF, et al. Effect of Amalgam restorations on whole body potassium and bone mineral content in older men. Gen Dent. 1996, 44(3): 246-8.
27. Knapp LT, Klann E. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem. 2000.
28. Badou A, et al. HgCl2-induced IL-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through L-type calcium channels. J Biol Chem. 1997 Dec 19; 272(51): 32411-8.
29. Freitas AJ, et al. Effects of Hg2+ and CH3Hg+ on Ca2+ fluxes in the rat brain. Brain Research. 1996; 738(2): 257-64.
30. Yallapragoda PR, et al. Inhibition of calcium transport by Hg salts in rat cerebellum and cerebral cortex. J Appl Toxicol. 1996, 164(4): 325-30.
31. Szucs A, et al. Effects of inorganic mercury and methylmercury on the ionic currents of cultured rat hippocampal neurons. Cell Mol Neurobiol. 1997; 17(3): 273-8.
32. Busselberg D. Calcium channels as target sites of heavy metals. Toxicol Lett. 1995 Dec; 82-83: 255-61.
33. Lu SC, Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 1999; 13(10):1169-83.
34. Parsons, RB. Expression of cysteine dioxygenase (EC 126.96.36.199) and sulfite oxidase in the human lung: a potential role for sulfate production in the protection from airborne xenobiotica. J Hepatol. 1998; 29(4):595-602.
35. Zalups RK, et al. Nephrotoxicity of inorganic mercury co-administered with L-cysteine. Toxicology. 1996; 109(1): 15-29.
36. Wilkinson LJ, Waring RH. Cysteine dioxygenase: Modulation of expression in human cell lines by cytokines and control of sulphate production. Toxicol In Vitro. 2002 Aug; 16(4): 481-3.
37. Gordon C, et al. Abnormal sulphur oxidation in systemic lupus erythrmatosus (SLE). Lancet. 1992; 339(8784): 25-6.
38. Emory P, et al. Poor sulphoxidation in patients with rheumatoid arthritis. Ann Rheum Dis. 1992; 51(3): 318-20.
39. Bradley H, et al. Sulfate metabolism is abnormal in patients with rheumatoid arthritis. Confirmation by in vivo biochemical findings. J Rheumatol. 1994; 21(7):1192-6.
40. Perry TL, et al. Hallevorden-Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency. Ann Neural. 1985; 18(4): 482-489.
41. Chang LW, Hartmann HA. Blood-brain barrier dysfunction in experimental mercury intoxication. Acta Neuropathol (Berlin). 1972; 21(3): 179-84.
42. Ware RA, Chang LW, Burkholder PM. An Ultrastructural study on the blood-brain barrier dysfunction following mercury intoxication. Acta Neurolpathol (Berlin). 1974; 30(3): 211-214.
43. Chang LW. Prenatal and neonatal toxicology and pathology of heavy metals. Adv Pharmacol Chemother. 1980; 17:195-231.
44. Arvidson B, Arvidsson J, Johansson K. Mercury deposits in neurons of the trigeminal ganglia after insertion of dental amalgam in rats. Biometals. 1994; 7(3): 261-263.
45. Arvidson B. Inorganic mercury is transported from muscular nerve terminals to spinal and brainstem motorneurons. Muscle Nerve. 1992, 15: 1089-94.
46. Candura SM, et al. Effects of mercuric chloride and methyl mercury on cholinergic neuromuscular transmission. Pharmacol Toxicol. 1997; 80(5): 218-24.
47. Anderson, C. Exposure to mercury linked to neurobehavioral disease epidemic in children. Green Bay Chronicle. July 30, 2004. www.safeminds.org/pressroom/press_releases/30July2004-GreenBayNews.pdf
48. Elferink JG. Thimerosal: A versatile sulfhydryl reagent, calcium mobilizer, and cell function modulating agent. Gen Pharmacol. 1999 Jul; 33(1): 1-6.
49. Mercola J. Learn how mercury is affecting you and the ones you love. 2014. www.mercola.com/article/mercury/no_mercury.htm
50. Improvement of nerve and immunological damages after amalgam removal. Amer. J of Probiotic Dentistry and Medicine. Jan 1991.
51. Zamm AF. Removal of dental mercury: often an effective treatment for very sensitive patients. J Orthomolecular Med. 1990; 5(53):138-142.
52. Clark, H. The Cure of All Diseases. New Century Press, 2002.
53. van Benschoten MM, Acupoint energetics of mercury toxicity and amalgam removal with case studies. American Journal of Acupuncture. 1994; 22(3): 251-262.
54. Autism Treatments. http://www.healing-arts.org/children/holmes.htm
55. Life Enhancement. http://www.life-enhancement.com/
56. Blaylock Wellness Report. http://www.blaylockreport.com/
57. Salonen JT, Nyyssonen K, Salonen R. Fish intake and the risk of coronary disease. N.Eng. J.Med. 1995 Oct 5; 333(14): 937.
58. Harvard Medical School Family Health Guide http://www.health.harvard.edu/fhg/Darchive/diseases.1101.shtml